social media Blogs

09|10|25

Why Influence Is the New Front Door in Pharma

We’re no longer living in a mass media world—we’re living in a trust economy. That’s the powerful message from Susan Perlbachs, Chief Creative Officer, in her latest article for Med Ad News (PharmaLive). Read more to discover how influence is reshaping the future of pharma marketing. 

09|10|24

With Ads on Threads, Is It Time for an All-Meta Strategy?

Justin Chase, EVP, Media, was recently published in Med Ad News discussing the benefits of using Meta's buying platform including exactly how much cost savings advertisers can find and how. Read the article to learn more.

03|05|24

How Subscriptions Are Changing the Way We Consume and Advertise on Social Media

In a recent article published by Med Ad News and PharmaLive.com, Justin Chase, EVP, Media, highlights why privacy on social media comes with a price and how subscriptions are changing how we consume and advertise on social media. Read more.

02|14|24

How the New Media Landscape Is Rendering Traditional Media Agencies Obsolete

Is your brand positioned for success in today's media landscape? In this blog, Justin Chase, EVP, Media, explains how the new media landscape is rendering traditional media agencies obsolete and what you can do to take advantage of these trends.

07|18|23

Threading the Needle: Is Meta’s Threads Headed for Success?

Will Meta's new Threads matter to pharma advertisers? When will we know if it's a success? We give you answers from Justin Chase, EVP, EVERSANA INTOUCH Media, along with recent news coverage with his expertise.

06|02|23

Engage, Educate, Empower, Equalize: Justin Chase Talks to PharmaLive/Med Ad News

Recently, Justin Chase spoke with Maria Fontanazza of PharmaLive and Med Ad News. Read a few of his quotes here, then check out the whole interview!

12|07|22

Pharma Worries as Twitter Upheaval Continues

Justin Chase, SVP, Media, EVERSANA INTOUCH, was interviewed by Endpoints News reporter Beth Snyder Bulick for an article on pharmaceutical advertising on Twitter in the platform's current state of disarray.